• WagnasT@piefed.world
    link
    fedilink
    English
    arrow-up
    20
    ·
    23 hours ago

    in mice.

    Still promising, but you can almost always append “in mice” to these kinds of headlines.

      • altphoto@lemmy.today
        link
        fedilink
        English
        arrow-up
        3
        ·
        15 hours ago

        Only rich people can rebuild and ride the titan submarine and recreate the view of the Titanic.

    • PancakesCantKillMe@lemmy.world
      link
      fedilink
      English
      arrow-up
      8
      ·
      22 hours ago

      Of course, but they’ve also seen the effects in human tissue samples. Also this reference about already having used the inhibitor in human volunteers for muscle weakness shows good promise:

      Blau added, “Phase 1 clinical trials of a 15-PGDH inhibitor for muscle weakness have shown that it is safe and active in healthy volunteers. Our hope is that a similar trial will be launched soon to test its effect in cartilage regeneration. …”

  • happybadger [he/him]@hexbear.net
    link
    fedilink
    English
    arrow-up
    4
    ·
    1 day ago

    Human cartilage samples taken from knee replacement surgeries also responded positively.

    It’s always so bleak reading about this phase of clinical trials. Orthopaedic surgery is wildly brutal and these patients were 5-10 years away from being able to avoid the lifetime of trauma that comes with it. lt’s a complete roll of the chronological dice whether you’ll be the tissue sample that proves a 100% fatal cancer treatment works or the patient in a phase 3 trial with a 50% survival rate or the patient who gets the little beepboop thing that turns it into an inconvenience.